With this study, we explored and demonstrated the applicability and value of orthogonal and complementary label-free technologies for enhanced serotype-independent characterization of key properties and stability profiles of rAAV5 samples.
Discover blogs, whitepapers, application notes and more, to help you find solutions to challenges to the viral vector characterization challenges you’re currently facing.
BLOG: Delving deeper into AAV attributes
Overcoming challenges, in design, processing, formulation and quality control with analytics.
App Note: Identifying critical quality attributes of rAAV samples
Rapid, accurate, and robust measurements of viral titer & full capsid content for AAV samples.
Measuring viral titer
Measuring viral titer at different stages of the development and production with light scattering.
Our webinars address the real challenges being faced in the development and manufacturing of viral vectors – and show you how analytical technology can help you overcome them.
Finding fit-for-purpose analytics
Carina Rodenstein, Scientist at Leukocare AG, compares analytical techniques for assessing AAV stability.
AAV Analysis: viral titer and capsid empty/full ratios
Learn how advanced multi-detector GPC/SEC can help extend characterization of AAV serotypes
More on-demand webinars
Discover more webinars covering various aspects of viral vector characterization.